Join Julia Sobotka, Research Genetic Counsellor and Program Manager of the CHARM consortium, on September 26 at 7 p.m. ET, for a deep dive into the hereditary factors that can lead to ovarian cancer. In this session you will learn about the differences between sporadic and hereditary cancer, and Julia will explore cell-free DNA testing, its benefits and limitations in relation to early cancer detection, and discuss a new clinical trial using cell-free DNA testing for early cancer detection in patients with hereditary cancer syndromes.
#Clinicaltrialsandresearch